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Advances in Renal Osteodystrophy—
IV International Symposium
Throughout recent years, one of the most dynamic min D relationship, with special emphasis placed on
pathogenesis and on the well-known role that geneticsand quickly growing areas in the field of nephrology has
plays. Epidemiologic aspects are also underlined, alongbeen renal osteodystrophy. Despite the fact that bone
with the possible role of estrogens in the regulation ofmetabolic disorders have always been one of the most
bone metabolism in patients with chronic renal failure.important complications associated with chronic renal
Given the fact that hyperphosphatemia has recentlyfailure, they have, until recently, only been linked to
been mentioned as one of the conditions directly relatedmorbidity in chronic renal failure patients, and never to
to death, special attention has been paid to highlightingmortality.
the most innovative and effective methods of managingIn the last few years, many studies and articles explor-
this condition.ing the link between the various cardiovascular and bone
Another factor that has important implications andmetabolic disorders experienced by chronic renal failure
repercussions in clinical practice is the treatment of sec-patients have appeared. This, in turn, has provoked a
ondary hyperparathyroidism in patients with chronic re-marked increase in interest in the area of renal osteodys-
nal failure. As there are many new perspectives comingtrophy. Furthermore, advances in molecular biology
through in this area, some of the studies selected are
techniques now permit the in-depth study of the role devoted to examining vitamin D–related aspects, such
that genetics plays in these bone metabolic disorders as its new analogs and administrative techniques. Fur-
and makes a significant contribution to the knowledge thermore, other treatments that have major implications
already possessed about this area of nephrology. for the future of the management of hyperparathyroid-
The Fourth International Symposium on Renal Osteo- ism are examined in detail, such as the use of calcimimet-
dystrophy, held every five years in Oviedo, Spain, ex- ics, bisphosphonates, and the injection of alcohol directly
plored the global advances made in renal osteodystrophy into hyperplasic glands. One review focuses on a descrip-
by way of 24 lectures given by invited speakers and tive analysis of exactly when and in whom parathyroidec-
through the presentation of 91 scientific works submitted tomy should be performed when all other medical treat-
to the Symposium. In this Kidney International supple- ment methods have failed.
ment, 30 of the most relevant and original works have Finally, given the important relationship between
been selected from among all of these contributions in bone metabolism and cardiovascular disorders, several
of the selected articles analyze this relationship fromorder to cover the many subfields of this subject area.
different perspectives, with the intention of updating,The first part of the supplement is centered on some
and reflecting upon, the role that the different cardiovas-of the basic areas of interest in bone metabolism. For
cular risk factors have in patients with chronic renalexample, the regulation of bone remodeling and funda-
failure.mental aspects of the calcium-parathyroid hormone-vita-
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